Adroit Infotech Rights Issue 2024 vs Genpharmasec Rights Issue 2024

Comparison between Adroit Infotech Rights Issue 2024 and Genpharmasec Rights Issue 2024.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Adroit Infotech Rights Issue 2024 and Genpharmasec Rights Issue 2024. Adroit Infotech Rights Issue 2024 is listed on BSE, NSE while Genpharmasec Rights Issue 2024 is listed on BSE.

 Adroit Infotech LimitedGenpharmasec Limited
LogoAdroit Infotech Rights Issue 2024 LogoGenpharmasec Rights Issue 2024 Logo
Listing AtBSE, NSEBSE
Terms of Payment

Issue Price of Rs.15/- to be paid as Rs.3.75/- per share on Application and Rs.11.75/- per share in one or more calls as may be determined by the Board at its sole discretion from time to time.

Full amount of Rs.1.75 per Equity Share is payable on application.

Entitlement3 Rights Equity Share(s) for every 2 fully paid-up Equity Shares held on Record Date1 Rights Equity Share(s) for every 1 fully paid-up Equity Shares held on Record Date
Application FormApplication Form Application Form
Letter of Offer Letter of Offer Letter of Offer
RegistrarVenture Capital & Corporate Investments Ltd.Purva Sharegistry (India) Pvt.Ltd.
Lead Managers

Rights Issue Size and Price

The issue size of Adroit Infotech Rights Issue 2024 rights issue is ₹48.75 Crores, whereas Genpharmasec Rights Issue 2024 rights issue size is ₹48.45 Crores.

 Adroit Infotech LimitedGenpharmasec Limited
Issue Size3,25,01,058 shares27,68,59,850 shares
Issue Size (Amount)₹48.75 Crores₹48.45 Crores
Issue Price₹15 per share₹1.75 per share
Face Value₹10 per share₹1 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of Adroit Infotech Rights Issue 2024 is Jan 19, 2024 while record date of Genpharmasec Rights Issue 2024 is Jan 09, 2024.

 Adroit Infotech LimitedGenpharmasec Limited
Record DateJan 19, 2024Jan 09, 2024
Credit of Rights Entitlements
Bid/Offer Opens OnFeb 07, 2024Jan 23, 2024
Renunciation of Rights EntitlementsFeb 12, 2024Feb 02, 2024
Bid/Offer Closes OnFeb 16, 2024Feb 13, 2024
Deemed Date of AllotmentFeb 23, 2024Feb 16, 2024
Credit DateFeb 28, 2024Feb 21, 2024
Listing DateMar 04, 2024Feb 26, 2024

Financials details

Comparison of Adroit Infotech Rights Issue 2024 and Genpharmasec Rights Issue 2024 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

 Adroit Infotech LimitedGenpharmasec Limited
Financial

Adroit Infotech Limited Financial Information (Restated Consolidated)

Adroit Infotech Limited's revenue increased by 250.28% and profit after tax (PAT) rose by 511.49% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended31 Mar 202331 Mar 202231 Mar 2021
Assets34.2117.5114.46
Revenue22.726.497.07
Profit After Tax3.780.62-0.00
Net Worth
Reserves and Surplus
Total Borrowing
Amount in ₹ Crore

Genpharmasec Limited Financial Information (Restated)

Genpharmasec Limited's revenue decreased by -6.56% and profit after tax (PAT) rose by 637.15% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended31 Mar 202331 Mar 202231 Mar 2021
Assets19.8821.6527.82
Revenue25.6227.4121.64
Profit After Tax1.12-0.211.26
Net Worth29.9128.7828.99
Reserves and Surplus28.7828.99
Total Borrowing3.08
Amount in ₹ Crore

Compare with others

Compare: